KEGG: ece:Z2608
STRING: 155864.Z2608
ydgC is a bacterial protein found in gram-negative bacteria, particularly in Escherichia coli (strain K12) and Shigella flexneri. It functions as a component involved in lipopolysaccharide (LPS) assembly pathways . LPS is a critical constituent of the outer membrane of gram-negative bacteria that contributes to membrane integrity, bacterial survival, and pathogenesis.
Understanding ydgC is particularly important in:
Bacterial cell envelope biogenesis research
Membrane protein organization studies
Investigations of bacterial stress responses
Research on antimicrobial resistance mechanisms
Based on manufacturer specifications, commercially available ydgC antibodies have been validated for:
| Application | Validation Status | Typical Dilution Range |
|---|---|---|
| Western Blot (WB) | Validated | 1:500 - 1:2000 |
| ELISA | Validated | 1:1000 - 1:5000 |
These antibodies are primarily used in bacterial research settings focusing on membrane biology, stress responses, and bacterial adaptation mechanisms .
Commercial ydgC antibodies show species-specific reactivity patterns:
| Antibody Catalog | Target Organism | Cross-Reactivity | UniProt Reference |
|---|---|---|---|
| CSB-PA364875XA01ENV | E. coli (K12) | Limited to closely related Enterobacteriaceae | P0ACX0 |
| CSB-PA364876XA01SZB | Shigella flexneri | Primary reactivity with Shigella strains | P0ACX2 |
While these antibodies were raised against specific bacterial species, researchers should validate cross-reactivity when studying related bacterial strains . Sequence homology analysis suggests potential cross-reactivity within the Enterobacteriaceae family, but experimental validation is required for each research application.
Comprehensive validation of ydgC antibodies should follow these sequential steps:
Genetic validation: Test antibody reactivity in wild-type vs. ydgC knockout or knockdown bacterial strains
Peptide competition assays: Pre-incubate antibody with excess recombinant ydgC protein (provided as positive control with commercial antibodies) to confirm signal reduction
Multiple antibody approach: Compare results using antibodies from different suppliers or those targeting different epitopes
Orthogonal techniques: Correlate antibody-based detection with mRNA expression or mass spectrometry data
Following YCharOS open antibody characterization principles, researchers should document validation results methodically and consider sharing validation data with the research community .
Membrane proteins like ydgC present unique technical challenges that require specialized approaches:
Sample preparation optimization:
Compare multiple lysis buffers containing different detergents (Triton X-100, CHAPS, DDM)
Evaluate sonication vs. enzymatic vs. mechanical disruption methods
Test subcellular fractionation protocols to enrich membrane components
Signal enhancement strategies:
Employ signal amplification systems like tyramide signal amplification for immunodetection
Consider protein enrichment via immunoprecipitation before analysis
Optimize blocking conditions to reduce background (5% BSA typically superior to milk for membrane proteins)
Technical controls:
ydgC is implicated in LPS assembly, which undergoes significant remodeling during bacterial stress responses . Researchers can leverage ydgC antibodies to:
Quantify expression changes:
Monitor ydgC protein levels under stress conditions including:
Antibiotic exposure (particularly cell wall targeting agents)
pH stress
Osmotic stress
Nutrient limitation
Track subcellular localization:
Employ fractionation followed by immunoblotting to detect redistribution during stress
Consider immunofluorescence microscopy when optimized protocols are established
Identify binding partners:
Use co-immunoprecipitation with ydgC antibodies followed by mass spectrometry
Evaluate changes in protein-protein interactions under different stress conditions
Recommended Western Blot Protocol:
Sample preparation:
Harvest bacteria in mid-log phase (OD600 ≈ 0.6-0.8)
Resuspend in lysis buffer containing:
50 mM Tris-HCl pH 7.5
150 mM NaCl
1% Triton X-100 or 1% DDM
Protease inhibitor cocktail
Disrupt cells via sonication (6 × 10s pulses with 10s cooling)
Clarify lysate (14,000 × g, 15 min, 4°C)
Gel electrophoresis:
Load 20-40 μg total protein per lane
Use 12-15% SDS-PAGE (ydgC is a relatively small protein)
Include recombinant antigen as positive control
Transfer conditions:
Semi-dry transfer: 15V for 30 min
Or wet transfer: 100V for 1 hour in cold room
Immunodetection:
Optimized ELISA Protocol:
Plate preparation:
Coat 96-well plates with bacterial lysate (10 μg/mL) or purified recombinant ydgC (1-2 μg/mL) in carbonate buffer (pH 9.6)
Incubate overnight at 4°C
Wash 3× with PBST
Blocking and antibody incubation:
Block with 3% BSA in PBST (2 hours, room temperature)
Add primary antibody at 1:2000 dilution (2 hours, room temperature)
Wash 5× with PBST
Add HRP-conjugated anti-rabbit antibody at 1:5000 (1 hour, room temperature)
Wash 5× with PBST
Detection:
Add TMB substrate and monitor color development
Stop reaction with 2N H₂SO₄
Read absorbance at 450 nm
Controls and optimization:
To maximize antibody stability and performance:
Storage conditions:
Handling recommendations:
Keep on ice during experimental procedures
Add carrier protein (0.1% BSA) to diluted antibodies for enhanced stability
Use low-protein binding tubes for storage
Centrifuge briefly before opening to collect solution at tube bottom
Quality control practices:
Include positive controls in each experiment to monitor antibody performance
Document lot numbers and maintain consistency within projects
Perform regular validation assays to monitor antibody performance over time
Consider antibody titration experiments for each new lot
Complementary approaches enhance the value of ydgC antibody-based research:
Multi-omics integration:
Correlate protein levels (detected by antibodies) with transcriptomics data
Combine with metabolomics to assess impact of ydgC alterations on bacterial metabolism
Integrate with structural biology approaches to understand protein-protein interactions
Advanced microscopy applications:
Super-resolution microscopy to determine precise subcellular localization
Live-cell imaging using fluorescently labeled nanobodies derived from ydgC antibodies
FRET-based approaches to study ydgC interactions with other membrane components
Systems biology approaches:
Modern antibody engineering approaches can enhance research applications:
Affinity maturation:
In vitro evolution techniques can enhance binding affinity without sacrificing specificity
Directed mutagenesis of complementarity-determining regions (CDRs)
Selection strategies using phage or yeast display
Format optimization:
Generation of Fab fragments for improved tissue penetration and reduced background
Development of single-chain variable fragments (scFvs) for specialized applications
Creation of bispecific formats targeting ydgC and interacting partners simultaneously
Functionality enhancement:
Given ydgC's role in membrane biology, these antibodies offer valuable tools for studying host-pathogen interactions:
Virulence studies:
Examine ydgC expression during different stages of infection
Compare ydgC levels between virulent and attenuated strains
Correlate ydgC expression with antibiotic resistance profiles
Host-pathogen interaction analysis:
Investigate ydgC regulation during host cell attachment/invasion
Study ydgC expression changes in response to host immune factors
Evaluate ydgC as a potential diagnostic marker for bacterial infections
Therapeutic discovery applications:
Bacterial protein detection presents unique challenges compared to mammalian targets:
| Consideration | Bacterial Targets (e.g., ydgC) | Mammalian Targets |
|---|---|---|
| Specificity validation | Requires testing in knockout strains; challenging in some species | Established knockout cell lines often available |
| Cross-reactivity | Must consider bacterial species diversity | Species cross-reactivity often well-characterized |
| Sample preparation | Cell wall disruption critical; detergent selection important | Generally standardized protocols exist |
| Background issues | Bacterial components can cause non-specific binding | Well-established blocking protocols |
| Expression systems | Careful consideration of tags that may affect membrane localization | Variety of validated systems available |
Researchers should apply the comprehensive validation framework established by YCharOS but adapt protocols specifically for bacterial targets .
| Issue | Possible Causes | Recommended Solutions |
|---|---|---|
| Weak or no signal in Western blot | - Insufficient protein extraction - Low antibody concentration - Protein degradation | - Optimize lysis with membrane-specific detergents - Increase antibody concentration - Add additional protease inhibitors |
| High background | - Insufficient blocking - Antibody concentration too high - Non-specific binding | - Increase blocking time/concentration - Titrate antibody - Try alternative blocking agents (BSA vs. milk) |
| Multiple bands | - Cross-reactivity - Protein degradation - Post-translational modifications | - Validate with recombinant control - Use fresh samples with protease inhibitors - Compare with predicted molecular weight |
| Inconsistent results | - Batch-to-batch variation - Sample preparation differences - Growth condition variations | - Use consistent antibody lots - Standardize sample preparation - Control bacterial growth conditions carefully |
When analyzing ydgC expression data:
Quantification approaches:
Use densitometry with appropriate normalization controls
Consider multiple housekeeping controls specific for bacterial systems
Apply statistical analysis appropriate for the experimental design
Expression pattern analysis:
Correlate ydgC expression with phenotypic changes
Consider post-translational modifications affecting antibody recognition
Evaluate subcellular distribution changes alongside total expression
Experimental design considerations:
To ensure reproducibility in the scientific literature, researchers should:
Antibody reporting standards:
Provide complete antibody information (supplier, catalog number, lot, RRID)
Include detailed validation data specific to experimental conditions
Document all optimization steps and final protocol parameters
Controls documentation:
Describe all positive and negative controls used
Include validation experiments demonstrating specificity
Provide full blots/images with molecular weight markers in supplementary materials
Method transparency: